Onconova Therapeutics, Inc. (ONTX) belonging to the Healthcare sector has surged 18.25% and closed its last trading session at $0.5.
The company reported its EPS on 3/30/2018. Currently, the stock has a 1 Year Price Target of $3.45.
The consensus recommendation, according to Zacks Investment research, is 1. The scale runs from 1 to 5 with 1 recommending Strong Buy and 5 recommending a Strong Sell.
The Stock had a 1 Consensus Analyst Recommendation 30 Days Ago, whereas 60 days ago and 90 days ago the analyst recommendations were 1.67 and 1.67 respectively.
Onconova Therapeutics, Inc. on 3/30/2018 reported its EPS as $-0.29 with the analysts projecting the EPS of the stock as $-0.73. The company beat the analyst EPS Estimate with the difference of $0.44. This shows a surprise factor of 0.603%.
Many analysts have provided their estimated foresights on Onconova Therapeutics, Inc. Earnings, with 3 analysts believing the company would generate an Average Estimate of $-0.08.
Whereas they predicted High and Low Earnings Estimate as $-0.07 and $-0.08 respectively. While in the same Quarter Previous year, the Actual EPS was $-0.29.
Analysts are also projecting an Average Revenue Estimate for Onconova Therapeutics, Inc. as $220000 in the Current Quarter. This estimate is provided by 3 analysts.
Onconova Therapeutics, Inc. (ONTX) has the market capitalization of $9.03 Million. The company rocked its 52-Week High of $2.83 and touched its 52-Week Low of $0.33.
The stock has Return on Assets (ROA) of -216.6 percent. Return on Equity (ROE) stands at 312.3% and Return on Investment (ROI) of 221.1 percent.
The stock is currently showing YTD performance of -66.73 Percent. The company has Beta Value of 0.45 and ATR value of 0.04. The Weekly and Monthly Volatility stands at 10.94% and 9.14%.